{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:11Z","timestamp":1792096871453,"version":"4.4.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genome Ed."],"abstract":"<jats:p>Sickle cell anaemia (SCA) is one of the common autosomal recessive monogenic disorders, caused by a transverse point mutation (GAG &amp;gt; GTG) at the sixth codon of the beta-globin gene, which results in haemolytic anaemia due to the fragile RBCs. Recent progress in genome editing has gained attention for the therapeutic cure for SCA. Direct correction of SCA mutation by homology-directed repair relies on a double-strand break (DSB) at the target site and carries the risk of generating beta-thalassaemic mutations if the editing is not error-free. On the other hand, base editors cannot correct the pathogenic SCA mutation resulting from A &amp;gt; T base transversion. Prime editor (PE), the recently described CRISPR\/Cas 9 based gene editing tool that enables precise gene manipulations without DSB and unintended nucleotide changes, is a viable approach for the treatment of SCA. However, the major limitation with the use of prime editing is the lower efficiency especially in human erythroid cell lines and primary cells. To overcome these limitations, we developed a modular lenti-viral based prime editor system and demonstrated its use for the precise modelling of SCA mutation and its subsequent correction in human erythroid cell lines. We achieved highly efficient installation of SCA mutation (up to 72%) and its subsequent correction in human erythroid cells. For the first time, we demonstrated the functional restoration of adult haemoglobin without any unintended nucleotide changes or indel formations using the PE2 system. We also validated that the off-target effects mediated by the PE2 system is very minimal even with very efficient on-target conversion, making it a safe therapeutic option. Taken together, the modular lenti-viral prime editor system developed in this study not only expands the range of cell lines targetable by prime editor but also improves the efficiency considerably, enabling the use of prime editor for myriad molecular, genetic, and translational studies.<\/jats:p>","DOI":"10.3389\/fgeed.2022.1085111","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T02:08:50Z","timestamp":1671502130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2"],"prefix":"10.3389","volume":"4","author":[{"given":"Anila","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithin Sam","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanya","family":"Koikkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Rajendiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedhitha","family":"Devaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin Anand","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonkuzhali","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanabhavan","family":"Thangavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srujan","family":"Marepally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji R.","family":"Velayudhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumarasamypet M.","family":"Mohankumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/stcltm\/szac064","article-title":"CRISPRthripsis: The risk of CRISPR\/Cas9-induced chromothripsis in gene therapy","volume":"11","author":"Amendola","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"571239","DOI":"10.3389\/fgeed.2020.571239","article-title":"\u03b2-Hemoglobinopathies: The test bench for genome editing-based therapeutic strategies","volume":"2","author":"Barbarani","year":"2020","journal-title":"Front. Genome Ed."},{"key":"B5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/blood.V65.1.183.183","article-title":"Hemoglobin S polymerization: Primary determinant of the hemolytic and clinical severity of the sickling syndromes","volume":"65","author":"Brittenham","year":"1985","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/crispr.2021.0113","article-title":"Inference of CRISPR edits from sanger trace data","volume":"5","author":"Conant","year":"2022","journal-title":"CRISPR J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.omtm.2020.04.013","article-title":"\u03b2T87Q-globin gene therapy reduces sickle hemoglobin production, allowing for ex vivo anti-sickling activity in human erythroid cells","volume":"17","author":"Demirci","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"360ra134","DOI":"10.1126\/scitranslmed.aaf9336","article-title":"Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells","volume":"8","author":"DeWitt","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","article-title":"Designing and executing prime editing experiments in mammalian cells","volume":"17","author":"Doman","year":"2022","journal-title":"Nat. Protoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"22154","DOI":"10.1038\/s41598-021-01689-2","article-title":"A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines","volume":"11","author":"Eggenschwiler","year":"2021","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2029392","article-title":"Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease","volume":"384","author":"Esrick","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41467-022-28442-1","article-title":"Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair","volume":"13","author":"Ferreira da Silva","year":"2022","journal-title":"Nat. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1016\/j.ymthe.2022.07.001","article-title":"A truncated reverse transcriptase enhances prime editing by split AAV vectors","volume":"30","author":"Gao","year":"2022","journal-title":"Mol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41587-021-00891-x","article-title":"Genome-wide specificity of prime editors in plants","volume":"39","author":"Jin","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of LentiGlobin for sickle cell disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: A review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"10576","DOI":"10.1093\/nar\/gkaa764","article-title":"Unbiased investigation of specificities of prime editing systems in human cells","volume":"48","author":"Kim","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: A method to quantify base editing from sanger sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e59890","DOI":"10.1371\/journal.pone.0059890","article-title":"Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells","volume":"8","author":"Kurita","year":"2013","journal-title":"PLOS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e79208","DOI":"10.7554\/eLife.79208","article-title":"Highly efficient generation of isogenic pluripotent stem cell models using prime editing","volume":"11","author":"Li","year":"2022","journal-title":"eLife"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9862","DOI":"10.3390\/ijms23179862","article-title":"Prime editing: An all-rounder for genome editing","volume":"23","author":"Lu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1182\/blood.2019000949","article-title":"Lentiviral and genome-editing strategies for the treatment of \u03b2-hemoglobinopathies","volume":"134","author":"Magrin","year":"2019","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic stem cell gene therapy: Progress and lessons learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","article-title":"Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR\/Cas9-Mediated gene editing","volume":"5","author":"Ortinski","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1038\/s41467-021-26097-y","article-title":"Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing","volume":"12","author":"Papathanasiou","year":"2021","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1126\/science.1065806","article-title":"Correction of sickle cell disease in transgenic mouse models by gene therapy","volume":"294","author":"Pawliuk","year":"2001","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41587-021-00901-y","article-title":"CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells","volume":"40","author":"Petri","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J. Clin. Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s11033-021-06479-7","article-title":"CRISPR\/Cas based gene editing: Marking a new era in medical science","volume":"48","author":"Prasad","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.omtm.2018.08.003","article-title":"Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with \u03b2-thalassemia major","volume":"10","author":"Psatha","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e65421","DOI":"10.7554\/eLife.65421","article-title":"Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin","volume":"11","author":"Ravi","year":"2022","journal-title":"eLife"},{"key":"B38","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fphys.2020.00435","article-title":"Recent advances in the treatment of sickle cell disease","volume":"11","author":"Salinas Cisneros","year":"2020","journal-title":"Front. Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1038\/s41467-020-19136-7","article-title":"Prime editing for functional repair in patient-derived disease models","volume":"11","author":"Schene","year":"2020","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/bjh.12413","article-title":"Sickle cell disease: Time for a closer look at treatment options?","volume":"162","author":"Sheth","year":"2013","journal-title":"Br. J. Haematol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"786893","DOI":"10.3389\/fgeed.2021.786893","article-title":"piggyPrime: High-Efficacy prime editing in human cells using piggyBac-based DNA transposition","volume":"3","author":"Wolff","year":"2021","journal-title":"Front. Genome Ed."},{"key":"B43","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt.4194","article-title":"Optimized base editors enable efficient editing in cells, organoids and mice","volume":"36","author":"Zafra","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","article-title":"Therapeutic base editing of human hematopoietic stem cells","volume":"26","author":"Zeng","year":"2020","journal-title":"Nat. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.3390\/ijms23095002","article-title":"Prime editor 3 mediated beta-thalassemia mutations of the HBB gene in human erythroid progenitor cells","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Genome Editing"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2022.1085111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T02:08:53Z","timestamp":1671502133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2022.1085111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":46,"alternative-id":["10.3389\/fgeed.2022.1085111"],"URL":"https:\/\/doi.org\/10.3389\/fgeed.2022.1085111","relation":{},"ISSN":["2673-3439"],"issn-type":[{"value":"2673-3439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"article-number":"1085111"}}